The following words and terms, when used in this chapter, shall
have the following meanings, unless the contents indicate otherwise.
(1) ACLS--Advanced Cardiac Life Support, as defined
by the AHA.
(2) AED--Automatic External Defibrillator.
(3) AHA--American Heart Association.
(4) Analgesics--Dangerous or scheduled drugs that alleviate
pain, but not including non-opioid based drugs such as acetaminophen
or non-steroidal anti-inflammatory drugs (NSAIDs).
(5) Anesthesia--Use of local anesthetics (in amounts
that generate the effect of general anesthesia, regional anesthesia,
or monitored anesthesia care), analgesics, anxiolytics, and/or hypnotics
to create a loss of feeling or sensation by interrupting or depressing
(6) Anesthesia Services--The use of anesthesia for
the performance of Level II - IV services.
(7) Anxiolytics--Dangerous or scheduled drugs used
to provide sedation and/or to treat episodes of anxiety.
(8) ASHI--American Safety and Health Institute.
(9) ASA--American Society of Anesthesiologists.
(10) BLS--Basic Life Support, as defined by the AHA.
(11) Certified registered nurse anesthetist (CRNA)--A
person licensed by the Texas Board of Nursing (TBN) as a registered
professional nurse, authorized by the TBN as an advanced practice
nurse in the role of nurse anesthetist, and certified by a national
certifying body recognized by the TBN.
(12) Dangerous drugs--Medications defined by the Texas
Dangerous Drug Act, Chapter 483, Texas Health and Safety Code. Dangerous
drugs require a prescription, but are not included in the list of
scheduled drugs. A dangerous drug bears the legend "Caution: federal
law prohibits dispensing without a prescription" or "Prescription
(13) Hypnotics--Dangerous or scheduled drugs used to
induce unconsciousness. This includes inhaled anesthetics and nonvolatile
anesthetic agents such as Barbiturates, Benzodiazepines, Opioids,
Etomidate, Propofol, and Ketamine.
(14) Level I services--Delivery of analgesics or anxiolytics
by mouth, as prescribed for the patient on order of a physician, at
a dose level low enough to allow the patient to remain ambulatory.
(15) Level II services--
(A) The administration of tumescent anesthesia;
(B) The delivery of analgesics or anxiolytics by mouth
in dosages greater than allowed at Level I, as prescribed for the
patient on order of a physician; or
(C) Except as provided by §192.2(b)(9) of this
title (relating to Provision of Anesthesia Services in Outpatient
Settings), the administration of local anesthesia, peripheral nerve
blocks, or both in a total dosage amount that exceeds 50 percent of
the recommended maximum safe dosage per outpatient visit.
(16) Level III services--Delivery of analgesics or
anxiolytics other than by mouth, including intravenously, intramuscularly,
(17) Level IV services--Delivery of general anesthetics,
including regional anesthetics and monitored anesthesia care; spinal,
epidural, or caudal blocks for the purposes of providing anesthesia
or monitored anesthesia care.
(18) Local Anesthetics--Dangerous drugs administered
topically or by injection, which interrupt nerve conduction, temporarily
creating a loss of sensation to an affected area and that generate
the effect of general anesthesia, regional anesthesia, or monitored
(19) Monitored anesthesia care--Includes all aspects
of anesthesia care by an anesthesiologist or member of the anesthesia
care team including the administration of sedatives, analgesics, hypnotics
and other anesthesia agents or medications necessary to ensure patient
safety and comfort. May include situations where a patient undergoing
a diagnostic or therapeutic procedure receives doses of medication
that create a risk of loss of normal protective reflexes or loss of
consciousness and the patient remains able to protect the airway during
the procedure. If the patient is rendered unconscious and loses normal
protective reflexes, then anesthesia care shall be considered a general
(20) Outpatient setting--Any facility, clinic, center,
office, or other setting that is not a part of a licensed hospital
or a licensed ambulatory surgical center with the exception of the
(A) a clinic located on land recognized as tribal land
by the federal government and maintained or operated by a federally
recognized Indian tribe or tribal organization as listed by the United
States secretary of the interior under 25 U.S.C. §479-1 or as
listed under a successor federal statute or regulation;
(B) a facility maintained or operated by a state or
(C) a clinic directly maintained or operated by the
United States or by any of its departments, officers, or agencies;
(D) an outpatient setting where the facility itself
is accredited by either The Joint Commission relating to ambulatory
surgical centers, the American Association for Accreditation of Ambulatory
Surgery Facilities, or the Accreditation Association for Ambulatory
(21) Board--The Texas Medical Board.
(22) PALS--Pediatric Advanced Life Support, as defined
by the AHA.
(23) Peripheral nerve block--The injection of local
anesthetics into an area of the body directly adjacent to a peripheral
nerve, for the purpose of blocking the response to pain in the distribution
of sensation of that nerve.
(24) Physician--A person licensed by the Texas Medical
Board as a medical doctor or doctor of osteopathic medicine who diagnoses,
treats, or offers to treat any disease or disorder, mental or physical,
or any physical deformity or injury by any system or method or effects
cures thereof and charges therefore, directly or indirectly, money
or other compensation. "Physician" and "surgeon" shall be construed
(25) Scheduled Drugs--Medications defined by the Texas
Controlled Substances Act, Chapter 481, Texas Health and Safety Code.
This Act establishes five categories, or schedules of drugs, based
on risk of abuse and addiction. (Schedule I includes drugs that carry
an extremely high risk of abuse and addiction and have no legitimate
medical use. Schedule V includes drugs that have the lowest abuse/addiction
(26) Tumescent Anesthesia--A specialized type of subcutaneous
infiltration of a dilute mixture of local anesthetic and epinephrine
known as tumescent solution.
|Source Note: The provisions of this §192.1 adopted to be effective May 21, 2000, 25 TexReg 4350; amended to be effective June 29, 2006, 31 TexReg 5107; amended to be effective November 30, 2009, 34 TexReg 8539; amended to be effective May 2, 2010, 35 TexReg 3281; amended to be effective May 15, 2012, 37 TexReg 3583; amended to be effective March 18, 2013, 38 TexReg 1875; amended to be effective January 20, 2014, 39 TexReg 284